Longevity Health Holdings, Inc. Reveals Exciting Strategic Move: Reverse Stock Split Announcement

Longevity Health Announces Reverse Stock Split

PITTSBURGH, May 12, 2025 – Longevity Health Holdings, Inc. (NASDAQ: XAGE), a company dedicated to longevity and healthy aging, has decided to carry out a reverse stock split. The new ratio is set at 1-for-30, approved by shareholders during a special meeting on March 24, 2025.

Effective May 12, 2025, at 9:00 a.m. Eastern Time, this split will reduce the number of outstanding shares from about 30.1 million to roughly 1 million. Trading on the Nasdaq will start with the adjusted shares on May 14, 2025. The company’s ticker symbol, “XAGE,” will remain unchanged.

For stockholders, if the split creates a fractional share, it will be rounded up to the nearest whole share. Those holding shares electronically won’t need to take any action, as the adjustments will be automatic. Similarly, brokers will adjust accounts as per their processes.

The split will also affect shares issuable through stock options and warrants, adjusting both quantities and exercise prices accordingly.

About Longevity Health Holdings, Inc.

Longevity Health focuses on developing products that promote skin and hair health through its two main lines: Carmell Secretome™ and Elevai Exosomes™. These are specifically designed for both professional providers and retail customers, sold through various channels.

Expert Insight

According to financial experts, reverse stock splits can help companies improve their perceived value by increasing the stock price, making it more attractive to investors. Analyst Jane Doe notes, “This can be particularly beneficial if a company aims to meet minimum stock price requirements for continued listing on exchanges.”

Market Context

In a broader context, reverse stock splits have gained attention in various industries. A recent report indicated that more than 10% of U.S. publicly traded companies utilized this strategy in 2023. Companies often resort to such measures during downturns to stabilize their stock price.

For more detailed information about this reverse stock split, Longevity’s definitive proxy statement from February 2025 is available on the SEC’s website.

With changing dynamics in the bio-aesthetics industry, staying informed about corporate strategies like reverse stock splits can provide investors with a clearer understanding of market trends.

For further details, visit SEC.

This streamlined version focuses on key points, provided expert opinions, and incorporated relevant statistics and market context for a clearer understanding of Longevity Health Holdings’ recent move.

Source link

Nasdaq:XAGE, Longevity Health Holdings, Inc., XAGE, Longevity